{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T16:19:37Z","timestamp":1789402777472,"version":"build-2803163510"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,29]],"date-time":"2022-10-29T00:00:00Z","timestamp":1667001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,10,29]],"date-time":"2022-10-29T00:00:00Z","timestamp":1667001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-022-01860-3","type":"journal-article","created":{"date-parts":[[2022,10,29]],"date-time":"2022-10-29T07:04:37Z","timestamp":1667027077000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Drug susceptibility testing of circulating lung cancer cells for personalized treatment"],"prefix":"10.1007","volume":"40","author":[{"given":"Ajay","family":"Balakrishnan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antony George Francis","family":"Thottian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Govind Babu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8975-5108","authenticated-orcid":false,"given":"Prashant","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,29]]},"reference":[{"key":"1860_CR1","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1101\/gad.305805.117","volume":"31","author":"DS Micalizzi","year":"2017","unstructured":"Micalizzi DS, Maheswaran S, Haber DA. A conduit to metastasis: circulating tumor cell biology. Genes Dev. 2017;31:1827\u201340.","journal-title":"Genes Dev"},{"key":"1860_CR2","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1038\/onc.2015.192","volume":"35","author":"K Pantel","year":"2016","unstructured":"Pantel K, Speicher MR. The biology of circulating tumor cells. Oncogene. 2016;35:1216\u201324.","journal-title":"Oncogene"},{"key":"1860_CR3","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1056\/NEJMoa040766","volume":"351","author":"M Cristofanilli","year":"2004","unstructured":"Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Matera J, Miller MC, Reuben JM, Doyle GV, Allard WJ, Terstappen LW, et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med. 2004;351:781\u201391.","journal-title":"N Engl J Med"},{"key":"1860_CR4","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1093\/annonc\/mdy172","volume":"29","author":"D Lorente","year":"2018","unstructured":"Lorente D, Olmos D, Mateo J, Dolling D, Bianchini D, Seed G, Flohr P, Crespo M, Figueiredo I, Miranda S, et al. Circulating tumour cell increase as a biomarker of disease progression in metastatic castration-resistant prostate cancer patients with low baseline CTC counts. Ann Oncol. 2018;29:1554\u201360.","journal-title":"Ann Oncol"},{"key":"1860_CR5","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13073-020-00728-3","volume":"12","author":"F Castro-Giner","year":"2020","unstructured":"Castro-Giner F, Aceto N. Tracking cancer progression: from circulating tumor cells to metastasis. Genome Med. 2020;12:31.","journal-title":"Genome Med"},{"key":"1860_CR6","first-page":"763","volume":"8","author":"Q Huang","year":"2018","unstructured":"Huang Q, Hu X, He W, Zhao Y, Hao S, Wu Q, Li S, Zhang S, Shi M. Fluid shear stress and tumor metastasis. Am J Cancer Res. 2018;8:763\u201377.","journal-title":"Am J Cancer Res"},{"key":"1860_CR7","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/306879","volume":"2012","author":"Y-N Kim","year":"2012","unstructured":"Kim Y-N, Koo KH, Sung JY, Yun U-J, Kim H. Anoikis resistance: an essential prerequisite for tumor metastasis. Int J Cell Biol. 2012;2012: 306879.","journal-title":"Int J Cell Biol"},{"key":"1860_CR8","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nature17038","volume":"529","author":"J Massague","year":"2016","unstructured":"Massague J, Obenauf AC. Metastatic colonization by circulating tumour cells. Nature. 2016;529:298\u2013306.","journal-title":"Nature"},{"key":"1860_CR9","doi-asserted-by":"publisher","first-page":"39975","DOI":"10.1038\/srep39975","volume":"7","author":"S Regmi","year":"2017","unstructured":"Regmi S, Fu A, Luo KQ. High shear stresses under exercise condition destroy circulating tumor cells in a microfluidic system. Sci Rep. 2017;7:39975.","journal-title":"Sci Rep"},{"key":"1860_CR10","doi-asserted-by":"publisher","first-page":"6304701","DOI":"10.1155\/2018\/6304701","volume":"2018","author":"WC Wang","year":"2018","unstructured":"Wang WC, Zhang XF, Peng J, Li XF, Wang AL, Bie YQ, Shi LH, Lin MB. Survival mechanisms and influence factors of circulating tumor cells. Biomed Res Int. 2018;2018:6304701.","journal-title":"Biomed Res Int"},{"key":"1860_CR11","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/nrc3820","volume":"14","author":"C Alix-Panabieres","year":"2014","unstructured":"Alix-Panabieres C, Pantel K. Challenges in circulating tumour cell research. Nat Rev Cancer. 2014;14:623\u201331.","journal-title":"Nat Rev Cancer"},{"key":"1860_CR12","doi-asserted-by":"publisher","first-page":"606","DOI":"10.2741\/4824","volume":"25","author":"A Balakrishnan","year":"2020","unstructured":"Balakrishnan A, George IA, Kumar P. Circulating tumor cells as an emerging tool in cancer therapy. Front Biosci (Landmark Ed). 2020;25:606\u201331.","journal-title":"Front Biosci (Landmark Ed)"},{"key":"1860_CR13","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s00109-016-1500-6","volume":"95","author":"C Alix-Panabieres","year":"2017","unstructured":"Alix-Panabieres C, Mader S, Pantel K. Epithelial\u2013mesenchymal plasticity in circulating tumor cells. J Mol Med (Berl). 2017;95:133\u201342.","journal-title":"J Mol Med (Berl)"},{"key":"1860_CR14","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s12967-021-03227-0","volume":"20","author":"AP Jain","year":"2022","unstructured":"Jain AP, Sambath J, Sathe G, George IA, Pandey A, Thompson EW, Kumar P. Pan-cancer quantitation of epithelial-mesenchymal transition dynamics using parallel reaction monitoring-based targeted proteomics approach. J Transl Med. 2022;20:84.","journal-title":"J Transl Med"},{"key":"1860_CR15","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/978-1-4939-3363-1_8","volume-title":"Circulating tumor cells","author":"BL Khoo","year":"2016","unstructured":"Khoo BL, Kumar P, Lim CT, Thiery JP. Genesis of circulating tumor cells through epithelial\u2013mesenchymal transition as a mechanism for distant dissemination. In: Cote RJ, Datar RH, editors. Circulating tumor cells. New York: Springer; 2016. p. 139\u201382."},{"key":"1860_CR16","doi-asserted-by":"publisher","first-page":"43710","DOI":"10.1038\/srep43710","volume":"7","author":"S Yadavalli","year":"2017","unstructured":"Yadavalli S, Jayaram S, Manda SS, Madugundu AK, Nayakanti DS, Tan TZ, Bhat R, Rangarajan A, Chatterjee A, Gowda H, et al. Data-driven discovery of extravasation pathway in circulating tumor cells. Sci Rep. 2017;7:43710.","journal-title":"Sci Rep"},{"key":"1860_CR17","doi-asserted-by":"publisher","first-page":"15578","DOI":"10.18632\/oncotarget.3903","volume":"6","author":"BL Khoo","year":"2015","unstructured":"Khoo BL, Lee SC, Kumar P, Tan TZ, Warkiani ME, Ow SG, Nandi S, Lim CT, Thiery JP. Short-term expansion of breast circulating cancer cells predicts response to anti-cancer therapy. Oncotarget. 2015;6:15578\u201393.","journal-title":"Oncotarget"},{"key":"1860_CR18","doi-asserted-by":"publisher","first-page":"7933","DOI":"10.1038\/s41598-019-44404-y","volume":"9","author":"A Balakrishnan","year":"2019","unstructured":"Balakrishnan A, Koppaka D, Anand A, Deb B, Grenci G, Viasnoff V, Thompson EW, Gowda H, Bhat R, Rangarajan A, et al. Circulating tumor cell cluster phenotype allows monitoring response to treatment and predicts survival. Sci Rep. 2019;9:7933.","journal-title":"Sci Rep"},{"issue":"9","key":"1860_CR19","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.3390\/jcm8091473","volume":"8","author":"T De","year":"2019","unstructured":"De T, Goyal S, Balachander G, Chatterjee K, Kumar P, Babu KG, Rangarajan A. A novel ex vivo system using 3D polymer scaffold to culture circulating tumor cells from breast cancer patients exhibits dynamic E-M phenotypes. J Clin Med. 2019;8(9):1473.","journal-title":"J Clin Med"},{"key":"1860_CR20","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1158\/0008-5472.CAN-14-2613","volume":"75","author":"L Cayrefourcq","year":"2015","unstructured":"Cayrefourcq L, Mazard T, Joosse S, Solassol J, Ramos J, Assenat E, Schumacher U, Costes V, Maudelonde T, Pantel K, et al. Establishment and characterization of a cell line from human circulating colon cancer cells. Can Res. 2015;75:892\u2013901.","journal-title":"Can Res"},{"key":"1860_CR21","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.cell.2014.08.016","volume":"159","author":"D Gao","year":"2014","unstructured":"Gao D, Vela I, Sboner A, Iaquinta PJ, Karthaus WR, Gopalan A, Dowling C, Wanjala JN, Undvall EA, Arora VK, et al. Organoid cultures derived from patients with advanced prostate cancer. Cell. 2014;159:176\u201387.","journal-title":"Cell"},{"key":"1860_CR22","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1158\/0008-5472.CAN-15-0145","volume":"75","author":"S Maheswaran","year":"2015","unstructured":"Maheswaran S, Haber DA. Ex vivo culture of ctcs: an emerging resource to guide cancer therapy. Can Res. 2015;75:2411\u20135.","journal-title":"Can Res"},{"key":"1860_CR23","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1126\/science.1253533","volume":"345","author":"M Yu","year":"2014","unstructured":"Yu M, Bardia A, Aceto N, Bersani F, Madden MW, Donaldson MC, Desai R, Zhu H, Comaills V, Zheng Z, et al. Cancer therapy. ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility. Science. 2014;345:216\u201320.","journal-title":"Science"},{"key":"1860_CR24","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.1600274","volume":"2","author":"BL Khoo","year":"2016","unstructured":"Khoo BL, Grenci G, Jing T, Lim YB, Lee SC, Thiery JP, Han J, Lim CT. Liquid biopsy and therapeutic response: circulating tumor cell cultures for evaluation of anticancer treatment. Sci Adv. 2016;2: e1600274.","journal-title":"Sci Adv"},{"key":"1860_CR25","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s10637-009-9369-7","volume":"29","author":"I Abdel-Karim","year":"2011","unstructured":"Abdel-Karim I, Plunkett WK Jr, O\u2019Brien S, Giles F, Thomas D, Faderl S, Ravandi F, Rios MB, Du M, Schneck KB, et al. A phase I study of pemetrexed in patients with relapsed or refractory acute leukemia. Invest New Drugs. 2011;29:323\u201331.","journal-title":"Invest New Drugs"},{"key":"1860_CR26","doi-asserted-by":"publisher","first-page":"199","DOI":"10.3892\/br.2016.714","volume":"5","author":"T Wada","year":"2016","unstructured":"Wada T, Fukuda T, Kawanishi M, Tasaka R, Imai K, Yamauchi M, Kasai M, Hashiguchi Y, Ichimura T, Yasui T, et al. Pharmacokinetic analyses of carboplatin in a patient with cancer of the fallopian tubes undergoing hemodialysis: a case report. Biomed Rep. 2016;5:199\u2013202.","journal-title":"Biomed Rep"},{"key":"1860_CR27","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.3389\/fonc.2020.01457","volume":"10","author":"KK Mangalaparthi","year":"2020","unstructured":"Mangalaparthi KK, Patel K, Khan AA, Manoharan M, Karunakaran C, Murugan S, Gupta R, Khanna-Gupta A, Chaudhuri A, Kumar P, et al. Mutational landscape of esophageal squamous cell carcinoma in an indian cohort. Front Oncol. 2020;10:1457.","journal-title":"Front Oncol"},{"key":"1860_CR28","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/nature12624","volume":"501","author":"CE Meacham","year":"2013","unstructured":"Meacham CE, Morrison SJ. Tumour heterogeneity and cancer cell plasticity. Nature. 2013;501:328\u201337.","journal-title":"Nature"},{"key":"1860_CR29","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1111\/j.1572-0241.2000.02091.x","volume":"95","author":"M Gambarin-Gelwan","year":"2000","unstructured":"Gambarin-Gelwan M, Wolf DC, Shapiro R, Schwartz ME, Min AD. Sensitivity of commonly available screening tests in detecting hepatocellular carcinoma in cirrhotic patients undergoing liver transplantation. Am J Gastroenterol. 2000;95:1535\u20138.","journal-title":"Am J Gastroenterol"},{"key":"1860_CR30","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/nrc882","volume":"2","author":"SS Gambhir","year":"2002","unstructured":"Gambhir SS. Molecular imaging of cancer with positron emission tomography. Nat Rev Cancer. 2002;2:683\u201393.","journal-title":"Nat Rev Cancer"},{"key":"1860_CR31","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/nrclinonc.2009.63","volume":"6","author":"RK Jain","year":"2009","unstructured":"Jain RK, Duda DG, Willett CG, Sahani DV, Zhu AX, Loeffler JS, Batchelor TT, Sorensen AG. Biomarkers of response and resistance to antiangiogenic therapy. Nat Rev Clin Oncol. 2009;6:327\u201338.","journal-title":"Nat Rev Clin Oncol"},{"key":"1860_CR32","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/nrclinonc.2010.61","volume":"7","author":"C Kim","year":"2010","unstructured":"Kim C, Paik S. Gene-expression-based prognostic assays for breast cancer. Nat Rev Clin Oncol. 2010;7:340\u20137.","journal-title":"Nat Rev Clin Oncol"},{"key":"1860_CR33","doi-asserted-by":"publisher","first-page":"248","DOI":"10.3181\/00379727-214-44093","volume":"214","author":"MJ Briske-Anderson","year":"1997","unstructured":"Briske-Anderson MJ, Finley JW, Newman SM. The influence of culture time and passage number on the morphological and physiological development of Caco-2 cells. Proc Soc Exp Biol Med Soc Exp Biol Med. 1997;214:248\u201357.","journal-title":"Proc Soc Exp Biol Med Soc Exp Biol Med"},{"key":"1860_CR34","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S0304-3835(97)04599-0","volume":"113","author":"CM Chang-Liu","year":"1997","unstructured":"Chang-Liu CM, Woloschak GE. Effect of passage number on cellular response to DNA-damaging agents: cell survival and gene expression. Cancer Lett. 1997;113:77\u201386.","journal-title":"Cancer Lett"},{"key":"1860_CR35","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/s10540-005-2797-5","volume":"24","author":"SL Wenger","year":"2004","unstructured":"Wenger SL, Senft JR, Sargent LM, Bamezai R, Bairwa N, Grant SG. Comparison of established cell lines at different passages by karyotype and comparative genomic hybridization. Biosci Rep. 2004;24:631\u20139.","journal-title":"Biosci Rep"},{"key":"1860_CR36","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646\u201374.","journal-title":"Cell"},{"key":"1860_CR37","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1038\/nm.3600","volume":"20","author":"CL Hodgkinson","year":"2014","unstructured":"Hodgkinson CL, Morrow CJ, Li Y, Metcalf RL, Rothwell DG, Trapani F, Polanski R, Burt DJ, Simpson KL, Morris K, et al. Tumorigenicity and genetic profiling of circulating tumor cells in small-cell lung cancer. Nat Med. 2014;20:897\u2013903.","journal-title":"Nat Med"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-022-01860-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-022-01860-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-022-01860-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T03:29:51Z","timestamp":1673839791000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-022-01860-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,29]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1]]}},"alternative-id":["1860"],"URL":"https:\/\/doi.org\/10.1007\/s12032-022-01860-3","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,29]]},"assertion":[{"value":"4 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no potential conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the ethics committee of Kidwai Memorial Institute of Oncology, Bangalore, India. Moreover, informed consent has been obtained from all the patients included in the study. The authors declare that the study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent has been obtained from all the patients included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors affirm that human research participants provided informed consent for publication of the images in Figs. ,  and  and Supplementary Table 1.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"1"}}